Advertisement

Topics

BRIEF-Intrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund

04:24 EDT 23 Sep 2016 | Reuters

* Entered into exclusive channel collaborations with Genten Therapeutics, CRS Bio, cos backed by Harvest Intrexon Enterprise Fund

Original Article: BRIEF-Intrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Intrexon to Develop Disease-Modifying Therapies in New Collaborations with Harvest Intrexon Enterprise Fund"

Quick Search
Advertisement